Search research articles
Contact Us
Filters
Showing results (541-550 of 544) with videos related to
Page
of 55
Sort By:
You have reached the last page of results.
This site can display upto 544 results.
Nature Chemical Biology
|
January 31, 2017
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Wei Qi, Kehao Zhao, Justin Gu, et al.
Journal of Medicinal Chemistry
|
March 30, 2022
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
Ying Huang, Martin Sendzik, Jeff Zhang, et al.
Addiction (Abingdon, England)
|
November 12, 2023
'No evidence of harm' implies no evidence of safety: Framing the lack of causal evidence in gambling advertising research
Philip Newall, Youssef Allami, Maira Andrade, et al.
Nature Medicine
|
October 20, 2015
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao, Joshua M Korn, Stéphane Ferretti, et al.
Page
of 55
Search research articles
Search
Showing results (541-550 of 544) with videos related to
Sort By:
Page
of 55
You have reached the last page of results.
This site can display upto 544 results.
Nature Chemical Biology
|
January 31, 2017
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Wei Qi, Kehao Zhao, Justin Gu, et al.
Journal of Medicinal Chemistry
|
March 30, 2022
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
Ying Huang, Martin Sendzik, Jeff Zhang, et al.
Addiction (Abingdon, England)
|
November 12, 2023
'No evidence of harm' implies no evidence of safety: Framing the lack of causal evidence in gambling advertising research
Philip Newall, Youssef Allami, Maira Andrade, et al.
Nature Medicine
|
October 20, 2015
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao, Joshua M Korn, Stéphane Ferretti, et al.
Page
of 55